Skip to content

Kiwifruit Effect on Periodontal Inflammation Kiwifruit Effect on Periodontal Inflammation

The Effect of Twice Daily Kiwifruit Consumption on Periodontal and Systemic Conditions Before and After Treatment: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03084484
Acronym
PERIO-KIWI
Enrollment
50
Registered
2017-03-21
Start date
2013-05-31
Completion date
2016-05-31
Last updated
2017-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Brief summary

The importance of micronutrients has been extensively reviewed and it was concluded that for prevention and treatment of periodontitis daily nutrition should include sufficient antioxidants, vitamin D and calcium. Up to now there is limited research available investigating the effect of vitamin C supplementation on the periodontal condition. Supplementation of vitamins and micronutrients has however raised numerous questions on clinical efficacy. Recently, a significant increase of medical literature on the effect of nutraceutical dietary aliments on general health has been noted. the aim of the present study is twofold. The first objective is to investigate the effect of twice-daily kiwifruit consumption as sole treatment modality in untreated periodontitis, followed after two months by initial periodontal therapy supported by continued kiwifruit consumption. The second objective is to investigate the effect of twice daily kiwifruit consumption on periodontal and systemic parameters of these periodontitis patients 3 months after treatment.

Interventions

DIETARY_SUPPLEMENTKiwifruit addition to the diet

Subjects were instructed to eat two kiwifruit per day during the whole study period. No recommendation on the type of kiwifruit, brand or origin was delivered. Kiwifruit was suggested to be taken as a whole and not mixed with sugar or other ingredients. No changes to their routinely dietary habits were suggested.

Non-surgical treatment of periodontal pockets with hand and ultrasonic instrumentation

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Single-centre randomized, parallel design, clinical trial with a 5-month follow

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* proximal attachment loss of ≥3 mm in ≥2 non-adjacent teeth, * PPD≥4 mm and bleeding on probing on at least 25 % of their total sites * documented radiographic bone loss

Exclusion criteria

* younger than 18 years or older than 70 years, * pregnant or lactating females, * females using contraceptive pharmacological medications, * reported diagnosis of any systemic illnesses including cardiovascular, renal, and liver diseases, * in need of antibiotic treatment during initial periodontal treatment (IPT), * IPT in the previous 6 months, * allergic to latex, kiwifruit and fruits in general, * suffering of eating or digestive disease or food intolerances, * smoking more than 20 cigarettes per day.

Design outcomes

Primary

MeasureTime frameDescription
Full-mouth bleeding score (FMBS)Baseline, 2 months and 3 months after periodontal treatmentChanges of FMBS. Unit of measure %

Secondary

MeasureTime frameDescription
Full-mouth plaque score (FMPS)Baseline, 2 months and 3 months after periodontal treatmentChanges in FMPS. Unit of measure %
Pocket probing depth (PPD)Baseline, 2 months and 3 months after periodontal treatmentChanges in PPD. Unit of measure: mm
Clinical attachment level (CAL)Baseline, 2 months and 3 months after periodontal treatmentChanges in CAL. Unit of measure: mm
Recession of the gingival margin (REC)Baseline, 2 months and 3 months after periodontal treatmentChanges in REC. Unit of measure: mm
TriglyceridesBaseline, 2 months and 3 months after periodontal treatmentChanges in triglycerides. Unit of measure: mmol/L
Low-density lipoprotein (LDL)Baseline, 2 months and 3 months after periodontal treatmentChanges in LDL. Unit of measure: mmol/L
Diastolic Blood Pressure (DBP)Baseline, 2 months and 3 months after periodontal treatmentChanges in DBP. Unit of measure: mmHg
CholesterolBaseline, 2 months and 3 months after periodontal treatmentChanges in total cholesterol, Unit of measure: mmol/L
Glycated HaemoglobinBaseline, 2 months and 3 months after periodontal treatmentChanges in Glycated haemoglobin. Unit of measure: mmol/mol
Vitamin CBaseline, 2 months and 3 months after periodontal treatmentChanges in Vitamin C. Unit of measure: µg/L
Systemic inflammationBaseline, 2 months and 3 months after periodontal treatmentChanges in C reactive protein (CRP). Unit of measure: mg/L
Systolic Blood Pressure (SBP)Baseline, 2 months and 3 months after periodontal treatmentChanges in SBP Unit of measure: mmHg
High-density lipoprotein (HDL)Baseline, 2 months and 3 months after periodontal treatmentChanges in HDL. Unit of measure: mmol/L

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026